Results
1
-
1
of
1
Cholesterol biosynthesis inhibitors as potent novel anti-cancer agents: suppression of hormone-dependent breast cancer by the oxidosqualene cyclase inhibitor RO 48-8071
,
Breast Cancer Research and Treatment
[DOI: 10.1007/s10549-014-2996-5]